Category Jumplist
Jumplist
- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Fujifilm Expects Clinical Trial Data On Avigan For COVID-19 In About A Month
The company will then work with Japanese regulators on submitting the drug for approval to treat COVID-19
Photo Credit : Reuters
1498454539_hwJsgQ_Fujifilm.jpg
Japan's Fujifilm Holdings Corp said on Thursday it expects data from a clinical trial of its Avigan drug on COVID-19 patients to be ready in about a month.
The last patient will enter the study on Aug. 16 and results will follow about a month after that, Fujifilm director Junji Okada said during a first-quarter earnings call.
The company will then work with Japanese regulators on submitting the drug for approval to treat COVID-19, he said.
(Reuters)